Perrigo

Phone: +61 2 9847 7999

Fax: +61 2 9847 7977

E-mail: AUCustomerService@perrigo.com

Web: https://www.perrigo.com.au/contact-us

Type	Public limited company
Traded as	NYSE: PRGO S&P 400 component
ISIN
Industry	Pharmaceutical
Predecessor	Perrigo Inc. (before the 2013 tax inversion to Ireland)
Founded	1887 (1887)
Headquarters	(Legal) Hogan Place, Dublin, Ireland (Operational) Grand Rapids, Michigan, U.S.
Key people	Murray S. Kessler, President and CEO, Board Member
Products	OTC RX API Medical Diagnostics Pharmaceuticals
Revenue	US$4.14 billion (2021)
Operating income	US$410 million (2021)
Net income	US$−69 million (2021)
Total assets	US$10.43 billion (2021)
Total equity	US$5.15 billion (2021)
Number of employees	9,900+ (2021)
Subsidiaries	Omega Pharma
Website	perrigo.com

Over 130 years of creating Quality, Affordable Self-Care Products to trusted retailers, pharmacies and e-commerce channels. Perrigo's branded and private label self-care products are available at retailers, pharmacies, and e-commerce outlets in the United States, across Europe, and in other major markets. Consumers want safe and effective products that support their health and well-being.

For detailed contact information visit location pages below.